Otsuka Global Regulatory Affairs has developed a CTA Planner (CTAP) that manages EU CTA submissions and correspondence to optimize processes, ensure accurate data, forecasting, portfolio transparency, and facilitate CTA-monitoring coverage (CTIS does not generate external notifications).

CTAP is integral in supporting EU CTR 536/2014 because it assists with planning and managing EU CTA submissions and correspondence using centralization and automation. Notably, CTAP enables EU CTA document planning and metadata compilation by multiple functions within an internal centralized tool prior to uploading in CTIS. Specifically, CTAP allows internal contributors as well as external CROs to populate metadata forms that mirror CTIS data and required documents. This centralization provides a single point to manage tasks, including preparing CTIS submission requests; assigning functional areas; providing CTIS data, documentation, and timelines; logging/resolving issues; and tracking submission and document workflow status. This also eliminates CRO need for CTIS access, which reduces the complexity of user management when there are multiple CROs. Additionally, automation allows collection of metadata subsets for use in project planning, scheduling, oversight, and metric reporting.  CTAP generates auto-notifications to contributors and QC reviewers, and provides status updates for pending and completed tasks.

Further, to overcome CTIS limitations related to user notifications, each EMA notice / alert is logged and linked to the related CTA submission in CTAP. Automated workflow for the logged notice or alert prompts the relevant functional area to acknowledge awareness and initiate a response if required.
CTAP is an innovative Otsuka global submission tracking and management tool that promotes quality, efficiency, and accountability in the CTA submission process through time-saving features such as automated notifications, tracking and updating workflows, capturing audit trails, and data analytics, all of which allow Otsuka to be one of few companies to immediately operationalize EU CTR upon CTIS going live on 31Jan2022. By utilizing CTAP, Otsuka has received authorization for a submitted CTA consisting of 10+ countries with 800+ documents. Recent CTAP enhancements include CTA progress dashboards, interactive user-friendly metadata e-forms, the ability to request multi-trial submissions such as Annual Safety Reports or CTA Modifications, and use of a distinct timetable for validation, evaluation, and Request for Information (RFI) timelines.

The authors wish to acknowledge Boris Reznichenko and Sasikanth Godavarty for their support in making this system a reality.

EU CTA Planner (CTAP): A Tool to Plan and Manage EU CTA Submissions and Correspondence in Support of EU CTR 536/2014

For it's 35th anniversary, DIA Europe is back in Basel, where all thought leaders meet in person to discuss, inspire, and network.

Join us in Basel: March 22-24, 2023

DIA Europe 2023 is designed to drive insights into action by connecting key policy discussions to real-world knowledge that you need for your everyday job. Your participation will accelerate your growth and your organization's performance in the drug development ecosystem.

Gathering innovative thought leaders from the entire life science landscape, DIA always has the aspiration to be ahead of current developments, reflected by 4 new content tracks in 2023:

- Artificial Intelligence and Data Science
- EU Health Policy and Regulatory Strategy
- Medical Devices and Combination Products
- Professional Development

DIA Europe 2023

A global, member-driven non-profit organization mobilizing life sciences and healthcare. DIA fosters innovation to improve health and well-being worldwide. Professionals from 80 countries continue to engage with DIA through our unparalleled membership network, educational offerings, and professional development opportunities.